Skip to main content
. 2022 Nov 18;4(11):e0794. doi: 10.1097/CCE.0000000000000794

TABLE 6.

Comparisons of Trial Metrics Between Community and Academic ICUs

Trial Metrics Community, n = 352 Academic, n = 2203 Total, n = 2555 p Adjusted for Center
Total approached for consent, n 410 2,888 3,298
Informed consent obtained, n 352 2203 2,555
Consent rate (%) 85.9 76.3 77.5 0.149
Monthly enrollment per 15-bed ICU, mean (sd) 2.1 (1.4) 1.1 (0.7) 1.3 (0.9) 0.119a
Coenrolled, n (%) 28 (8.0) 508 (23.1) 536 (21.0) 0.061
Protocol adherence
Either a) received study product or b) had a legitimate reason not to receive study product on ≥90% of ICU days, n (%) 319 (90.6) 2,019 (91.6) 2,338 (91.5) 0.207
Received at least one dose of study product, n (%) 348 (98.9) 2,187 (99.3) 2,535 (99.2) 0.422
No protocol violationb, n (%) 318 (90.3) 2,052 (93.1) 2,370 (92.8) 0.232

aCenter is the unit of analysis for month enrollment; therefore, a t test was performed without adjustment for center.

bNo protocol violation refers to patients who experienced none of the following: 1) received dose(s) of wrong study product, 2) received dose(s) not staggered by 4 hr when concurrently receiving a Lactobacillus-sensitive oral antibiotic, and 3) received dose(s) of open label probiotic.